Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment
Clinical trial NCT00825955 · COMPLETED
Trial details
- NCT number
- NCT00825955
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-17
- Primary completion
- 2011-11-15
- Enrollment
- 587
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.